Entrada Therapeutics (TRDA) Other Non-Current Assets (2020 - 2026)

Entrada Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $90000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 62.34% year-over-year to $90000.0; the TTM figure through Mar 2026 stood at $90000.0 (down 62.34% YoY), while the FY2025 annual figure was $3.3 million, up 1059.15% from the prior year.
• Other Non-Current Assets was $90000.0 for Q1 2026 at Entrada Therapeutics, down from $3.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.0 million in Q1 2022 to a low of $90000.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $3.0 million across 5 years, with a median of $4.0 million in 2022.
• Biggest YoY gain for Other Non-Current Assets was 1059.15% in 2025; the steepest drop was 93.95% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $4.0 million in 2022, then fell by 29.37% to $2.8 million in 2023, then sank by 89.82% to $284000.0 in 2024, then soared by 1059.15% to $3.3 million in 2025, then tumbled by 97.27% to $90000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $90000.0 (Q1 2026), $3.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.